Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction - Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial

被引:128
作者
Morrow, DA
Antman, EM
Sayah, A
Schuhwerk, KC
Giugliano, RP
deLemos, JA
Waller, M
Cohen, SA
Rosenberg, DG
Cutler, SS
McCabe, CH
Walls, RM
Braunwald, E
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, TIMI Study Grp, Dept Med, Boston, MA USA
[3] Good Samaritan Hosp, Dept Emergency Med, Brockton, MA USA
[4] SW Texas State Univ, Dept Med, Dallas, TX USA
[5] Centocor Inc, Malvern, PA USA
[6] Univ Florida, Div Cardiol, Miami, FL USA
[7] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA USA
关键词
D O I
10.1016/S0735-1097(02)01936-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial tested the feasibility of prehospital initiation of the bolus fibrinolytic reteplase (rPA) and determined the time saved by prehospital rPA in the setting of contemporary emergency cardiac care. BACKGROUND Newer bolus fibrinolytics have undergone only limited evaluation for prehospital administration. In addition, as door-to-drug times have decreased, the relevance of findings from prior trials of prehospital fibrinolysis has become less certain. METHODS Patients (n = 315) with ST-elevation myocardial infarction (STEMI) were enrolled in 20 emergency medical systems in North America. The time from emergency medical service (EMS) arrival to administration of a fibrinolytic was compared between study patients receiving prehospital rPA and sequential control patients from 6 to 12 months before the study who received a fibrinolytic in the hospital. RESULTS Acute myocardial infarction was confirmed in 98%. The median time from EMS arrival to initiation of rPA was 31 min (25th to 75th percentile, 24 min to 37 min). The time from EMS arrival to in-hospital fibrinolytic for 630 control patients was 63 min (25th to 75th percentile, 48 min to 89 min), resulting in a time saved of 32 min (p < 0.0001). By 30 min after first medical contact, 49% of study patients had received the first bolus of fibrinolytic compared with only 5% of controls (p < 0.0001). In-hospital mortality was 4.7%. Intracranial hemorrhage occurred in 1.0%. CONCLUSIONS Prehospital administration of rPA is a feasible approach to accelerating reperfusion in patients with STEMI. Valuable time savings can be achieved in the setting of contemporary transport and door-to-drug times and may translate into an improvement in clinical outcomes. (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 37 条
  • [1] [Anonymous], 1986, Lancet, V1, P397
  • [2] Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
    Antman, EM
    Gibson, CM
    de Lemos, JA
    Giugliano, RP
    McCabe, CH
    Coussement, P
    Menown, I
    Nienaber, CA
    Rehders, TC
    Frey, NJ
    Van der Wieken, R
    Andresen, D
    Scherer, J
    Anderson, K
    Van de Werf, F
    Braunwald, E
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (23) : 1944 - 1953
  • [3] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [4] Arntz HR, 1998, EUR HEART J, V19, P1140
  • [5] THE DIAGNOSTIC IMPACT OF PREHOSPITAL 12-LEAD ELECTROCARDIOGRAPHY
    AUFDERHEIDE, TP
    HENDLEY, GE
    THAKUR, RK
    MATEER, JR
    STUEVEN, HA
    OLSON, DW
    HARGARTEN, KM
    LAITINEN, F
    ROBINSON, N
    PREUSS, KC
    HOFFMAN, RG
    [J]. ANNALS OF EMERGENCY MEDICINE, 1990, 19 (11) : 1280 - 1287
  • [6] MILWAUKEE PREHOSPITAL CHEST PAIN PROJECT - PHASE-I - FEASIBILITY AND ACCURACY OF PREHOSPITAL THROMBOLYTIC CANDIDATE SELECTION
    AUFDERHEIDE, TP
    KEELAN, MH
    HENDLEY, GE
    ROBINSON, NA
    HASTINGS, TE
    LEWIN, RF
    HEWES, HF
    DANIEL, A
    ENGLE, D
    GIMBEL, BK
    BORTIN, KR
    CLARDY, DJ
    SCHMIDT, DH
    BAJWA, T
    HOLZHAUER, P
    DABROWSKI, RC
    SCHUCHARD, GH
    TEICHMAN, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (12) : 991 - 996
  • [7] EFFECTS OF CORONARY-ARTERY REPERFUSION ON MYOCARDIAL INFARCT SIZE AND SURVIVAL IN CONSCIOUS DOGS
    BAUGHMAN, KL
    MAROKO, PR
    VATNER, SF
    [J]. CIRCULATION, 1981, 63 (02) : 317 - 323
  • [8] TEMPORAL DEPENDENCE OF BENEFICIAL-EFFECTS OF CORONARY THROMBOLYSIS CHARACTERIZED BY POSITRON TOMOGRAPHY
    BERGMANN, SR
    LERCH, RA
    FOX, KAA
    LUDBROOK, PA
    WELCH, MJ
    TERPOGOSSIAN, MM
    SOBEL, BE
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) : 573 - 581
  • [9] Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
    Boersma, E
    Maas, ACP
    Deckers, JW
    Simoons, ML
    [J]. LANCET, 1996, 348 (9030) : 771 - 775
  • [10] BRUGEMANN J, 1992, EUR HEART J, V13, P787